Yonsei medical journal
-
Yonsei medical journal · Nov 2022
Antitumor Effect of Low-Dose of Rapamycin in a Transgenic Mouse Model of Liver Cancer.
We investigate whether low-dose rapamycin is effective in preventing hepatocellular carcinoma (HCC) growth and treating HCC after tumor development in transgenic mice. ⋯ Low-dose rapamycin might be effective to prevent HCC growth, but may be ineffective as a treatment option after HCC development.